{"id":4223,"date":"2020-05-22T18:48:23","date_gmt":"2020-05-23T01:48:23","guid":{"rendered":"https:\/\/www.iths.org\/participate\/?p=4223"},"modified":"2021-04-06T16:26:44","modified_gmt":"2021-04-06T23:26:44","slug":"seattle-covid-cohort-study-at-the-vtu","status":"publish","type":"post","link":"https:\/\/www.iths.org\/participate\/seattle-covid-cohort-study-at-the-vtu\/","title":{"rendered":"Seattle COVID-Cohort Study at the VTU"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row css_animation=&#8221;&#8221; row_type=&#8221;row&#8221; use_row_as_full_screen_section=&#8221;no&#8221; type=&#8221;full_width&#8221; angled_section=&#8221;no&#8221; text_align=&#8221;left&#8221; background_image_as_pattern=&#8221;without_pattern&#8221;][vc_column][vc_column_text]<\/p>\n<div class=\"box summary\"><\/div>\n<p>This study will assess the immune responses to SARS-CoV-2\/COVID-19 in three different groups. The body fights infection by producing different types of white blood cells that defend against foreign substances like viruses and bacteria. This process is called an immune response. The immune system responds in different ways that are not well understood. People experience different symptoms from SARS-CoV-2 infection. Different symptoms or the severity of COVID-19 may be due to differences in the immune system. We hope that by closely following the body\u2019s specific immune responses in people who have had COVID-19, people who become infected and people who remain negative even after possible exposure, we can better understand which responses may be required for a successful vaccine or treatment against SARS-CoV-2\/COVID-19.<\/p>\n<p>To join a COVID study: <a href=\"https:\/\/redcap.link\/COVID19-cohort\">https:\/\/redcap.link\/COVID19-cohort<\/a><br \/>\nFor more information: <a href=\"http:\/\/fredhutch.org\/covid-cohort\">fredhutch.org\/covid-cohort<\/a><\/p>\n<h3>Participant Eligibility<\/h3>\n<p>Over 18 years old<br \/>\nNot pregnant<br \/>\nAble to provide consent for the study<br \/>\nPhone screening to determine eligibility<br \/>\nAt risk for COVID (COVID-negative)<br \/>\nProvide positive test result \u2014 for diagnosed COVID positive volunteers<br \/>\nVisit to one of the study sites<\/p>\n<h3>Contact<\/h3>\n<p>Kim Louis<br \/>\n(206) 667-7510<\/p>\n<div class=\"box \">\n<h3 class=\"dets\">Additional Study Details<\/h3>\n<p><span class=\"st\"><strong>Full Study Title<\/strong><br \/>\nSeattle COVID-19 Cohort Study to Evaluate Immune Responses in Persons at Risk and with SARS-CoV-2 Infection<br \/>\n<\/span><\/p>\n<div class=\"lhalf sid\"><strong>Study ID:<\/strong> 10440<\/div>\n<div class=\"rhalf ctlink\"><strong>ClinicalTrials.gov Link:<\/strong><\/div>\n<div class=\"clear\"><\/div>\n<div class=\"lhalf start\"><strong>Start Date:<\/strong> 04\/08\/2020<\/div>\n<div class=\"rhalf end\"><strong>End Date:<\/strong> 12\/31\/2021<\/div>\n<div class=\"clear\"><\/div>\n<p><span class=\"pi\"><strong>Investigator(s)<\/strong><br \/>\nM. Juliana McElrath, MD, PhD<br \/>\n<\/span><br \/>\n<span class=\"healthy\"><strong>Accepts Healthy Volunteers?<\/strong><br \/>\nYes<\/span><\/p>\n<p><strong class=\"ssites\">Study Site(s)<\/strong><\/p>\n<div class=\"lhalf site1\">\n<h4>Cabrini Tower (First Hill)<\/h4>\n<p>901 Boren Ave #1320<br \/>\nSeattle, Washington 98104<\/p>\n<\/div>\n<div class=\"rhalf site2\">\n<h4>Fred Hutch (Eastlake)<\/h4>\n<p>1100 Fairview Ave N<br \/>\nSeattle Washington 98119<\/p>\n<\/div>\n<div class=\"clear\"><\/div>\n<p><\/div>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row css_animation=&#8221;&#8221; row_type=&#8221;row&#8221; use_row_as_full_screen_section=&#8221;no&#8221; type=&#8221;full_width&#8221; angled_section=&#8221;no&#8221; text_align=&#8221;left&#8221; background_image_as_pattern=&#8221;without_pattern&#8221;][vc_column][vc_column_text] This study will assess the immune responses to SARS-CoV-2\/COVID-19 in three different groups. The body fights infection by producing different types of white blood cells that defend against foreign substances like viruses and bacteria. This process is&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2,1123],"tags":[1124,1118,1125,1126],"class_list":["post-4223","post","type-post","status-publish","format-standard","hentry","category-healthy-volunteers","category-covid-19","tag-covid","tag-covid-19","tag-sars-cov-2","tag-sars-cov-2-covid-19-infection"],"_links":{"self":[{"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/posts\/4223","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/comments?post=4223"}],"version-history":[{"count":3,"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/posts\/4223\/revisions"}],"predecessor-version":[{"id":4629,"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/posts\/4223\/revisions\/4629"}],"wp:attachment":[{"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/media?parent=4223"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/categories?post=4223"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.iths.org\/participate\/wp-json\/wp\/v2\/tags?post=4223"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}